Browsing bySubjectInfliximab

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 5 of 5

Issue DateTitleAuthor(s)Type
2025Demand- Versus Supply-Side Policies in Market Penetration of Biosimilars: Which is More Effective?배승진Article
2016Efficacy and safety of infliximab therapy and predictors of response in korean patients with crohn’s disease: A nationwide, multicenter study정성애Article
2016Factors contributing to the preference of Korean patients with Crohn's disease when selecting an anti-tumor necrosis factor agent (Choice study)정성애Article
2019Infliximab treatment for intravenous immunoglobulin-resistant kawasaki disease: A multicenter study in Korea손세정Article
2025Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study김명규Article

BROWSE